AstraZeneca(AZN)

Sector:

Pharmaceuticals & Biotechnology

Index:

FTSE 100

Market Cap

£35,783m

Change Today

Price Down-81.00p

Share Price

2,474.00p

Sector movers: Investors seek cover in pharma stocks

Date: Tuesday 08 Jul 2008

LONDON (ShareCast) - Drugs giants GlaxoSmithKline and AstraZeneca are in demand as investors seek cover amid heavy falls seen across the FTSE 100 this morning. GlaxoSmithKline is more than 2% higher, while Astra has gained just over 1%.

Mining stocks are among those taking a battering. Anglo American leads the sector lower as metal prices slip back amid concerns that weakening economies will weigh on demand for industrial metals. South America-focused Antofagasta is also among the bottom 10 of the FTSE 100.

Top performing sectors so far today
Pharmaceuticals & Biotechnology 7,735.20 +1.85%
General Retailers 1,108.00 +1.82%
Electricity 8,095.60 +0.60%
Gas, Water & Multiutilities 4,374.40 +0.51%

Bottom performing sectors so far today
General Financial 6,025.70 -3.05%
Industrial Transportation 2,170.80 -2.77%
Mining 24,402.20 -2.65%
Banks 5,986.90 -2.48%

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 2,474.00p Price Down
Change Today -81.00p
52 Week High 2,766.00p
52 Week Low 1,748.00p
Volume 4,264,296
Shares Issued 1,446.35m
Market Cap £35,783m
Beta 0.59
RiskGrade 145

Performance Indicators

Compare performance with the sector and the market.
Find out more
Key: vs Market vs Sector
Value
68.02% below the market average68.02% below the market average68.02% below the market average68.02% below the market average68.02% below the market average
1.27% above the sector average1.27% above the sector average1.27% above the sector average1.27% above the sector average1.27% above the sector average
Price Trend
72.22% above the market average72.22% above the market average72.22% above the market average72.22% above the market average72.22% above the market average
75.28% above the sector average75.28% above the sector average75.28% above the sector average75.28% above the sector average75.28% above the sector average
Income
1.5% below the market average1.5% below the market average1.5% below the market average1.5% below the market average1.5% below the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Growth
46.16% below the market average46.16% below the market average46.16% below the market average46.16% below the market average46.16% below the market average
18.31% below the sector average18.31% below the sector average18.31% below the sector average18.31% below the sector average18.31% below the sector average
Price Chg 6m
93.53% above the market average93.53% above the market average93.53% above the market average93.53% above the market average93.53% above the market average
86.52% above the sector average86.52% above the sector average86.52% above the sector average86.52% above the sector average86.52% above the sector average
P/E
12.86% below the market average12.86% below the market average12.86% below the market average12.86% below the market average12.86% below the market average
36.84% above the sector average36.84% above the sector average36.84% above the sector average36.84% above the sector average36.84% above the sector average
PEG Not Available
Dividend Yield
1.56% above the market average1.56% above the market average1.56% above the market average1.56% above the market average1.56% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
EPS Growth
48.75% below the market average48.75% below the market average48.75% below the market average48.75% below the market average48.75% below the market average
53.85% below the sector average53.85% below the sector average53.85% below the sector average53.85% below the sector average53.85% below the sector average
Operating Margin
54.14% above the market average54.14% above the market average54.14% above the market average54.14% above the market average54.14% above the market average
94.67% above the sector average94.67% above the sector average94.67% above the sector average94.67% above the sector average94.67% above the sector average

What The Brokers Say

Strong Buy 14
Buy 3
Neutral 14
Sell 6
Strong Sell 4
Total 41
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  Interim Final
Ex-Div 06-Aug-08 06-Feb-08
Paid 15-Sep-08 17-Mar-08
Amount 55.00¢ 135.00¢

Trades for 06-Oct-2008

Time Volume / Share Price
13:30 768 @ 2,464.00p
13:56 1,143 @ 2,474.00p
13:56 1,674 @ 2,475.00p
13:56 350 @ 2,475.00p
13:56 134 @ 2,475.00p

AstraZeneca Key Personnel

CEO David R Brennan
CFO Simon Lowth

Digital Look have been voted
"Best Research and Informataion Provider"

4th Floor, Bankside House, 107 Leadenhall Street, London EC3A 4AF.
Registered in England and Wales (registered no. 3678570).

A good trader doesn’t blame
his tools…especially ours

The Marketmaker:Investor Edition Trading Tool Kit worth

£765.00!*

Open a spread betting account with
Marketmaker:Investor Edition today and receive

(Or click here to continue with your normal research on Digital Look)

Please remember that spread betting is a leveraged product and carries a high level of risk to your capital. It is possible to incur losses that exceed your initial investment. This product may not be suitable for all investors, therefore ensure you fully understand the risks involved and seek independent advice if necessary.
Digial Look is an Appointed Representative of CMC Spreadbet plc.